Repligen | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Agilent USD 410M 16M 2025-01
Align Technology USD 424.97M 9.17M 2024-12
Bio Techne USD 118.72M 7.35M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Bruker USD 247.3M 17.4M 2024-12
Charles River Laboratories USD 188.26M 946K 2024-12
Danaher USD 2.02B 185M 2024-12
Dentsply International USD 375M 13M 2024-12
Exact Sciences USD 370.43M 41.42M 2024-12
General Electric USD 1.16B 173M 2024-12
Henry Schein USD 737M 15M 2024-12
Illumina USD 263M 29M 2024-12
IQVIA Holdings USD 453M 69M 2024-12
Mettler Toledo International USD 237.34M 8.56M 2024-12
Myriad Genetics USD 136M 3.1M 2024-12
Patterson Companies 283.28M 40K 2024-10
Pfizer USD 4.27B 1.06B 2024-12
Repligen USD 75.61M 10.91M 2024-09
Revvity USD 255.62M 23.46M 2024-12
Standard Biotools USD 37.59M 3.18M 2024-12
Thermo Fisher Scientific USD 2.21B 114M 2024-12
Waters USD 173.27M 4.17M 2024-12
West Pharmaceutical Services USD 85.3M 1.8M 2024-12



Repligen Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.